Plus, rheumatology drug news, safety updates
EULAR 2014: Ultrasound Use Important for Rheumatology
Experts offer insight into ultrasound for joint counts in rheumatoid arthritis, synovial biopsies, Sjögren’s syndrome
Metabolic Syndrome Linked to Higher Risk for Immunological Disorders
Research suggests patients with metabolic disorders, such as diabetes, might benefit from antiinflammatory drugs used to treat immunlogical disorders
Kidney Problems More Prevalent in Patients with Rheumatoid Arthritis
Rheumatologists urged to monitor signs of kidney dysfunction in patients with RA as higher incidence of reduced kidney function found in these patients
Knee Replacement Offers Cardiovascular Benefits for Patients with Arthritis
Knee arthroplasty may help prevent cardiovascular disease in patients with osteoarthritis; same-day bilateral surgery safe for select patients with rheumatoid arthritis
Coding Corner Question: September
Coding for first infliximab infusion in patient with rheumatoid arthritis
Drugs Studied for Use in Rheumatoid Arthritis, Weight Loss
Plus, rheumatology drug news from EULAR 2014
EULAR 2014: Non-Tumor Necrosis Factor Biologics Update
Clinical trials on rheumatology drugs, including sarilumab, show promise for patients with rheumatoid arthritis also taking methotrexate
EULAR 2014: Biosimilar Drug Production Raises Concerns
Rheumatology experts question biosimilars’ safety, efficacy given their complex production process
EULAR 2014: Research on Rheumatoid Arthritis, Spondyloarthritis
Latest findings on rheumatological drug therapies, including methotrexate for RA, tumor necrosis factor inhibitors for SpA
- « Previous Page
- 1
- …
- 48
- 49
- 50
- 51
- 52
- …
- 73
- Next Page »